AGP Executive Report
Last update: 11 hours agoCardiovascular Drug Watch: CureGene says the first U.S. participant has been dosed in its pivotal trial of Evategrel (CG-0255), a new P2Y12 antiplatelet aimed at tackling clopidogrel resistance and faster, more consistent action. Public Health & Safety: Hong Kong’s Labour Department issued a heat-stress warning urging employers to prevent heat stroke with risk checks, rescheduling, shade/ventilation, and hydration/rest guidance. Wellness & Aging: International Yoga Day (theme: “Yoga for Healthy Ageing”) drew large crowds, including a Shanghai Bund Finance Centre event hosted by India’s consulate. Health Tech & Research: Chinese researchers reported a zebrafish semi-cloning method using haploid blastocyst cells, boosting success rates to about 30% and enabling one-step generation of gene-edited models. Clinical/Medical Case: A Chinese man’s extreme leg workout reportedly led to acute kidney failure and emergency dialysis, highlighting risks of overtraining. Biotech Deal Climate: China–U.S. cross-border biotech deals may slow slightly as Washington tightens investment and tech-transfer scrutiny, though big pharma partnerships are expected to keep growing. Health Workforce: Canada’s National Microbiology Laboratory is seeking new leadership as its vice-president steps down, amid ongoing Ebola preparedness work.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
